Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 237 entries
Sorted by: Best Match Show Resources per page
Proceedings of the Fourth Biennial Conference of the Society for Implementation Research Collaboration (SIRC) 2017: implementation mechanisms: what makes implementation work and why? part 1.

Implementation science : IS

Lewis CC, Stanick C, Lyon A, Darnell D, Locke J, Puspitasari A, Marriott BR, Dorsey CN, Larson M, Jackson C, Thayer J, Bailey CW, Lengnick-Hall R, Dorsey S, Landes SJ.
PMID: 29589570
Implement Sci. 2018 Mar 20;13:30. doi: 10.1186/s13012-018-0714-0.

No abstract available.

Cite
Lewis CC, Stanick C, Lyon A, et al. Proceedings of the Fourth Biennial Conference of the Society for Implementation Research Collaboration (SIRC) 2017: implementation mechanisms: what makes implementation work and why? part 1. Implement Sci. 2018;13:30doi: 10.1186/s13012-018-0714-0.
Lewis, C. C., Stanick, C., Lyon, A., Darnell, D., Locke, J., Puspitasari, A., Marriott, B. R., Dorsey, C. N., Larson, M., Jackson, C., Thayer, J., Bailey, C. W., Lengnick-Hall, R., Dorsey, S., & Landes, S. J. (2018). Proceedings of the Fourth Biennial Conference of the Society for Implementation Research Collaboration (SIRC) 2017: implementation mechanisms: what makes implementation work and why? part 1. Implementation science : IS, 1330. https://doi.org/10.1186/s13012-018-0714-0
Lewis, Cara C, et al. "Proceedings of the Fourth Biennial Conference of the Society for Implementation Research Collaboration (SIRC) 2017: implementation mechanisms: what makes implementation work and why? part 1." Implementation science : IS vol. 13 (2018): 30. doi: https://doi.org/10.1186/s13012-018-0714-0
Lewis CC, Stanick C, Lyon A, Darnell D, Locke J, Puspitasari A, Marriott BR, Dorsey CN, Larson M, Jackson C, Thayer J, Bailey CW, Lengnick-Hall R, Dorsey S, Landes SJ. Proceedings of the Fourth Biennial Conference of the Society for Implementation Research Collaboration (SIRC) 2017: implementation mechanisms: what makes implementation work and why? part 1. Implement Sci. 2018 Mar 20;13:30. doi: 10.1186/s13012-018-0714-0. PMID: 29589570; PMCID: PMC5872381.
Copy Download .nbib Format: NLM
Precision antimicrobial therapeutics: the path of least resistance?.

NPJ biofilms and microbiomes

Spaulding CN, Klein RD, Schreiber HL, Janetka JW, Hultgren SJ.
PMID: 29507749
NPJ Biofilms Microbiomes. 2018 Feb 27;4:4. doi: 10.1038/s41522-018-0048-3. eCollection 2018.

The emergence of drug-resistant pathogens has led to a decline in the efficacy of traditional antimicrobial therapy. The rise in resistance has been driven by widespread use, and in some cases misuse, of antibacterial agents in treating a variety...

Cite
Spaulding CN, Klein RD, Schreiber HL, et al. Precision antimicrobial therapeutics: the path of least resistance?. NPJ Biofilms Microbiomes. 2018;4:4doi: 10.1038/s41522-018-0048-3.
Spaulding, C. N., Klein, R. D., Schreiber, H. L., Janetka, J. W., & Hultgren, S. J. (2018). Precision antimicrobial therapeutics: the path of least resistance?. NPJ biofilms and microbiomes, 44. https://doi.org/10.1038/s41522-018-0048-3
Spaulding, Caitlin N, et al. "Precision antimicrobial therapeutics: the path of least resistance?." NPJ biofilms and microbiomes vol. 4 (2018): 4. doi: https://doi.org/10.1038/s41522-018-0048-3
Spaulding CN, Klein RD, Schreiber HL, Janetka JW, Hultgren SJ. Precision antimicrobial therapeutics: the path of least resistance?. NPJ Biofilms Microbiomes. 2018 Feb 27;4:4. doi: 10.1038/s41522-018-0048-3. eCollection 2018. PMID: 29507749; PMCID: PMC5829159.
Copy Download .nbib Format: NLM
Feasibility of the Tailored Activity Program for Hospitalized (TAP-H) Patients With Behavioral Symptoms.

The Gerontologist

Gitlin LN, Marx KA, Alonzi D, Kvedar T, Moody J, Trahan M, Van Haitsma K.
PMID: 27076056
Gerontologist. 2017 Jun;57(3):575-584. doi: 10.1093/geront/gnw052. Epub 2016 Apr 13.

PURPOSE OF THE STUDY: To evaluate feasibility of implementing the Tailored Activity Program for Hospitals (TAP-H) to improve engagement in patients with dementia admitted for behavioral disturbances.DESIGN AND METHODS: TAP-H involves up to 11 in-hospital sessions to develop activities...

Cite
Gitlin LN, Marx KA, Alonzi D, et al. Feasibility of the Tailored Activity Program for Hospitalized (TAP-H) Patients With Behavioral Symptoms. Gerontologist. 2016;57(3):575-584doi: 10.1093/geront/gnw052.
Gitlin, L. N., Marx, K. A., Alonzi, D., Kvedar, T., Moody, J., Trahan, M., & Van Haitsma, K. (2017). Feasibility of the Tailored Activity Program for Hospitalized (TAP-H) Patients With Behavioral Symptoms. The Gerontologist, 57(3), 575-584. https://doi.org/10.1093/geront/gnw052
Gitlin, Laura N, et al. "Feasibility of the Tailored Activity Program for Hospitalized (TAP-H) Patients With Behavioral Symptoms." The Gerontologist vol. 57,3 (2017): 575-584. doi: https://doi.org/10.1093/geront/gnw052
Gitlin LN, Marx KA, Alonzi D, Kvedar T, Moody J, Trahan M, Van Haitsma K. Feasibility of the Tailored Activity Program for Hospitalized (TAP-H) Patients With Behavioral Symptoms. Gerontologist. 2017 Jun;57(3):575-584. doi: 10.1093/geront/gnw052. Epub 2016 Apr 13. PMID: 27076056; PMCID: PMC5434496.
Copy Download .nbib Format: NLM
Optimized chemical coverage and data quality for non-targeted screening applications using liquid chromatography/high-resolution mass spectrometry.

Analytica chimica acta

Knolhoff AM, Kneapler CN, Croley TR.
PMID: 31027538
Anal Chim Acta. 2019 Aug 20;1066:93-101. doi: 10.1016/j.aca.2019.03.032. Epub 2019 Mar 18.

Non-targeted small molecule screening methods are used to analyze samples for potential compounds of interest without focusing on specific molecular species. There is great interest in these methods for metabolomic, environmental, forensic, and food safety applications, among others, to...

Cite
Knolhoff AM, Kneapler CN, Croley TR. Optimized chemical coverage and data quality for non-targeted screening applications using liquid chromatography/high-resolution mass spectrometry. Anal Chim Acta. 2019;1066:93-101doi: 10.1016/j.aca.2019.03.032.
Knolhoff, A. M., Kneapler, C. N., & Croley, T. R. (2019). Optimized chemical coverage and data quality for non-targeted screening applications using liquid chromatography/high-resolution mass spectrometry. Analytica chimica acta, 106693-101. https://doi.org/10.1016/j.aca.2019.03.032
Knolhoff, Ann M, et al. "Optimized chemical coverage and data quality for non-targeted screening applications using liquid chromatography/high-resolution mass spectrometry." Analytica chimica acta vol. 1066 (2019): 93-101. doi: https://doi.org/10.1016/j.aca.2019.03.032
Knolhoff AM, Kneapler CN, Croley TR. Optimized chemical coverage and data quality for non-targeted screening applications using liquid chromatography/high-resolution mass spectrometry. Anal Chim Acta. 2019 Aug 20;1066:93-101. doi: 10.1016/j.aca.2019.03.032. Epub 2019 Mar 18. PMID: 31027538.
Copy Download .nbib Format: NLM
The Evolving Role of Public Health in Medical Education.

Frontiers in public health

Rao R, Hawkins M, Ulrich T, Gatlin G, Mabry G, Mishra C.
PMID: 32714890
Front Public Health. 2020 Jun 26;8:251. doi: 10.3389/fpubh.2020.00251. eCollection 2020.

Medical education in the twentieth century was largely influenced by the Flexner Report, with significant proportions of instruction dedicated to the molecular underpinnings of the pathologic pathways and minimal mention of the socio-ecological determinants of health. When examining the...

Cite
Rao R, Hawkins M, Ulrich T, et al. The Evolving Role of Public Health in Medical Education. Front Public Health. 2020;8:251doi: 10.3389/fpubh.2020.00251.
Rao, R., Hawkins, M., Ulrich, T., Gatlin, G., Mabry, G., & Mishra, C. (2020). The Evolving Role of Public Health in Medical Education. Frontiers in public health, 8251. https://doi.org/10.3389/fpubh.2020.00251
Rao, Ravi, et al. "The Evolving Role of Public Health in Medical Education." Frontiers in public health vol. 8 (2020): 251. doi: https://doi.org/10.3389/fpubh.2020.00251
Rao R, Hawkins M, Ulrich T, Gatlin G, Mabry G, Mishra C. The Evolving Role of Public Health in Medical Education. Front Public Health. 2020 Jun 26;8:251. doi: 10.3389/fpubh.2020.00251. eCollection 2020. PMID: 32714890; PMCID: PMC7344251.
Copy Download .nbib Format: NLM
Pilot Intervention Addressing Social Support and Functioning of Low Socioeconomic Status Older Adults With ESRD: The Seniors Optimizing Community Integration to Advance Better Living with ESRD (SOCIABLE) Study.

Kidney medicine

Crews DC, Delaney AM, Walker Taylor JL, Cudjoe TKM, Nkimbeng M, Roberts L, Savage J, Evelyn-Gustave A, Roth J, Han D, Boyér LL, Thorpe RJ, Roth DL, Gitlin LN, Szanton SL.
PMID: 32734179
Kidney Med. 2019 Jan 24;1(1):13-20. doi: 10.1016/j.xkme.2018.12.001. eCollection 2019.

RATIONALE & OBJECTIVE: Older adults with end-stage kidney disease have increased morbidity, fatigue, and decreased physical function, which can inhibit self-care and social engagement. We pilot tested a home-based program to improve physical and social functioning of low socioeconomic...

Cite
Crews DC, Delaney AM, Walker Taylor JL, et al. Pilot Intervention Addressing Social Support and Functioning of Low Socioeconomic Status Older Adults With ESRD: The Seniors Optimizing Community Integration to Advance Better Living with ESRD (SOCIABLE) Study. Kidney Med. 2019;1(1):13-20doi: 10.1016/j.xkme.2018.12.001.
Crews, D. C., Delaney, A. M., Walker Taylor, J. L., Cudjoe, T. K. M., Nkimbeng, M., Roberts, L., Savage, J., Evelyn-Gustave, A., Roth, J., Han, D., Boyér, L. L., Thorpe, R. J., Roth, D. L., Gitlin, L. N., & Szanton, S. L. (2019). Pilot Intervention Addressing Social Support and Functioning of Low Socioeconomic Status Older Adults With ESRD: The Seniors Optimizing Community Integration to Advance Better Living with ESRD (SOCIABLE) Study. Kidney medicine, 1(1), 13-20. https://doi.org/10.1016/j.xkme.2018.12.001
Crews, Deidra C, et al. "Pilot Intervention Addressing Social Support and Functioning of Low Socioeconomic Status Older Adults With ESRD: The Seniors Optimizing Community Integration to Advance Better Living with ESRD (SOCIABLE) Study." Kidney medicine vol. 1,1 (2019): 13-20. doi: https://doi.org/10.1016/j.xkme.2018.12.001
Crews DC, Delaney AM, Walker Taylor JL, Cudjoe TKM, Nkimbeng M, Roberts L, Savage J, Evelyn-Gustave A, Roth J, Han D, Boyér LL, Thorpe RJ, Roth DL, Gitlin LN, Szanton SL. Pilot Intervention Addressing Social Support and Functioning of Low Socioeconomic Status Older Adults With ESRD: The Seniors Optimizing Community Integration to Advance Better Living with ESRD (SOCIABLE) Study. Kidney Med. 2019 Jan 24;1(1):13-20. doi: 10.1016/j.xkme.2018.12.001. eCollection 2019. PMID: 32734179; PMCID: PMC7380338.
Copy Download .nbib Format: NLM
Association Between Visual Field Damage and Gait Dysfunction in Patients With Glaucoma.

JAMA ophthalmology

E JY, Mihailovic A, Garzon C, Schrack JA, Li T, West SK, Gitlin LN, Friedman DS, Ramulu PY.
PMID: 34292297
JAMA Ophthalmol. 2021 Oct 01;139(10):1053-1060. doi: 10.1001/jamaophthalmol.2021.2617.

IMPORTANCE: Gait dysfunction is common in older people with visual impairment and is a major cause of falls.OBJECTIVE: To compare 3-year longitudinal changes in gait measures across the spectrum of baseline visual field (VF) damage in glaucoma.DESIGN, SETTING, AND...

Cite
E JY, Mihailovic A, Garzon C, et al. Association Between Visual Field Damage and Gait Dysfunction in Patients With Glaucoma. JAMA Ophthalmol. 2021;139(10):1053-1060doi: 10.1001/jamaophthalmol.2021.2617.
E, J. Y., Mihailovic, A., Garzon, C., Schrack, J. A., Li, T., West, S. K., Gitlin, L. N., Friedman, D. S., & Ramulu, P. Y. (2021). Association Between Visual Field Damage and Gait Dysfunction in Patients With Glaucoma. JAMA ophthalmology, 139(10), 1053-1060. https://doi.org/10.1001/jamaophthalmol.2021.2617
E, Jian-Yu, et al. "Association Between Visual Field Damage and Gait Dysfunction in Patients With Glaucoma." JAMA ophthalmology vol. 139,10 (2021): 1053-1060. doi: https://doi.org/10.1001/jamaophthalmol.2021.2617
E JY, Mihailovic A, Garzon C, Schrack JA, Li T, West SK, Gitlin LN, Friedman DS, Ramulu PY. Association Between Visual Field Damage and Gait Dysfunction in Patients With Glaucoma. JAMA Ophthalmol. 2021 Oct 01;139(10):1053-1060. doi: 10.1001/jamaophthalmol.2021.2617. PMID: 34292297; PMCID: PMC8299359.
Copy Download .nbib Format: NLM
WeCareAdvisor, an Online Platform to Help Family Caregivers Manage Dementia-Related Behavioral Symptoms: an Efficacy Trial in the Time of COVID-19.

Journal of technology in behavioral science

Gitlin LN, Bouranis N, Kern V, Koeuth S, Marx KA, McClure LA, Lyketsos CG, Kales HC.
PMID: 33786370
J Technol Behav Sci. 2021 Mar 25;1-12. doi: 10.1007/s41347-021-00204-8. Epub 2021 Mar 25.

Dementia-related behavioral and psychology symptoms (BPSD) are undertreated and have negative consequences. However, families do not have access to disease information, tailored problem-solving  and effective management strategies, and with COVID-19, are more socially isolated and distressed. To address this...

Cite
Gitlin LN, Bouranis N, Kern V, et al. WeCareAdvisor, an Online Platform to Help Family Caregivers Manage Dementia-Related Behavioral Symptoms: an Efficacy Trial in the Time of COVID-19. J Technol Behav Sci. 2021;1-12doi: 10.1007/s41347-021-00204-8.
Gitlin, L. N., Bouranis, N., Kern, V., Koeuth, S., Marx, K. A., McClure, L. A., Lyketsos, C. G., & Kales, H. C. (2021). WeCareAdvisor, an Online Platform to Help Family Caregivers Manage Dementia-Related Behavioral Symptoms: an Efficacy Trial in the Time of COVID-19. Journal of technology in behavioral science, 1-12. https://doi.org/10.1007/s41347-021-00204-8
Gitlin, Laura N, et al. "WeCareAdvisor, an Online Platform to Help Family Caregivers Manage Dementia-Related Behavioral Symptoms: an Efficacy Trial in the Time of COVID-19." Journal of technology in behavioral science vol. (2021): 1-12. doi: https://doi.org/10.1007/s41347-021-00204-8
Gitlin LN, Bouranis N, Kern V, Koeuth S, Marx KA, McClure LA, Lyketsos CG, Kales HC. WeCareAdvisor, an Online Platform to Help Family Caregivers Manage Dementia-Related Behavioral Symptoms: an Efficacy Trial in the Time of COVID-19. J Technol Behav Sci. 2021 Mar 25;1-12. doi: 10.1007/s41347-021-00204-8. Epub 2021 Mar 25. PMID: 33786370; PMCID: PMC7994055.
Copy Download .nbib Format: NLM
A Case of Adalimumab-Induced Granulomatous Interstitial Nephritis.

Cureus

Plant R, Rafi Ahmed A, Mchale T, Giblin L.
PMID: 34336477
Cureus. 2021 Jun 28;13(6):e15986. doi: 10.7759/cureus.15986. eCollection 2021 Jun.

Adalimumab is a monoclonal antibody targeting tumour necrosis factor-alpha (TNF-alpha) and is used for the treatment of numerous autoimmune conditions. There is a paucity of evidence linking adalimumab with granulomatous interstitial nephritis (GIN). We describe a renal biopsy-proven case...

Cite
Plant R, Rafi Ahmed A, Mchale T, et al. A Case of Adalimumab-Induced Granulomatous Interstitial Nephritis. Cureus. 2021;13(6):e15986doi: 10.7759/cureus.15986.
Plant, R., Rafi Ahmed, A., Mchale, T., & Giblin, L. (2021). A Case of Adalimumab-Induced Granulomatous Interstitial Nephritis. Cureus, 13(6), e15986. https://doi.org/10.7759/cureus.15986
Plant, Rory, et al. "A Case of Adalimumab-Induced Granulomatous Interstitial Nephritis." Cureus vol. 13,6 (2021): e15986. doi: https://doi.org/10.7759/cureus.15986
Plant R, Rafi Ahmed A, Mchale T, Giblin L. A Case of Adalimumab-Induced Granulomatous Interstitial Nephritis. Cureus. 2021 Jun 28;13(6):e15986. doi: 10.7759/cureus.15986. eCollection 2021 Jun. PMID: 34336477; PMCID: PMC8317671.
Copy Download .nbib Format: NLM
Impact of paternal presence and parental social-demographic characteristics on birth outcomes.

Journal of perinatal medicine

Bamanikar AA, Shah S, Aboudi D, Mikkilineni S, Giblin C, Lavan T, Brumberg HL.
PMID: 34355543
J Perinat Med. 2021 Aug 05;49(9):1154-1162. doi: 10.1515/jpm-2021-0078. Print 2021 Nov 25.

OBJECTIVES: Maternal race, marital status, and social environment impact risk of preterm delivery and size for gestational age. Although some paternal characteristics such as age are associated with pregnancy outcomes, the influence of the paternal presence, race/ethnicity and adverse...

Cite
Bamanikar AA, Shah S, Aboudi D, et al. Impact of paternal presence and parental social-demographic characteristics on birth outcomes. J Perinat Med. 2021;49(9):1154-1162doi: 10.1515/jpm-2021-0078.
Bamanikar, A. A., Shah, S., Aboudi, D., Mikkilineni, S., Giblin, C., Lavan, T., & Brumberg, H. L. (2021). Impact of paternal presence and parental social-demographic characteristics on birth outcomes. Journal of perinatal medicine, 49(9), 1154-1162. https://doi.org/10.1515/jpm-2021-0078
Bamanikar, Amruta A, et al. "Impact of paternal presence and parental social-demographic characteristics on birth outcomes." Journal of perinatal medicine vol. 49,9 (2021): 1154-1162. doi: https://doi.org/10.1515/jpm-2021-0078
Bamanikar AA, Shah S, Aboudi D, Mikkilineni S, Giblin C, Lavan T, Brumberg HL. Impact of paternal presence and parental social-demographic characteristics on birth outcomes. J Perinat Med. 2021 Aug 05;49(9):1154-1162. doi: 10.1515/jpm-2021-0078. Print 2021 Nov 25. PMID: 34355543.
Copy Download .nbib Format: NLM
Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release Calcifediol.

American journal of nephrology

Fadda G, Germain MJ, Broumand V, Nguyen A, McGarvey N, Gitlin M, Bishop CW, Ashfaq A.
PMID: 34818216
Am J Nephrol. 2021;52(10):798-807. doi: 10.1159/000518545. Epub 2021 Oct 27.

INTRODUCTION: The safety and efficacy of extended-release calcifediol (ERC) as a treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency (VDI) has been demonstrated in prospective randomized clinical...

Cite
Fadda G, Germain MJ, Broumand V, et al. Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release Calcifediol. Am J Nephrol. 2021;52(10):798-807doi: 10.1159/000518545.
Fadda, G., Germain, M. J., Broumand, V., Nguyen, A., McGarvey, N., Gitlin, M., Bishop, C. W., & Ashfaq, A. (2021). Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release Calcifediol. American journal of nephrology, 52(10), 798-807. https://doi.org/10.1159/000518545
Fadda, George, et al. "Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release Calcifediol." American journal of nephrology vol. 52,10 (2021): 798-807. doi: https://doi.org/10.1159/000518545
Fadda G, Germain MJ, Broumand V, Nguyen A, McGarvey N, Gitlin M, Bishop CW, Ashfaq A. Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release Calcifediol. Am J Nephrol. 2021;52(10):798-807. doi: 10.1159/000518545. Epub 2021 Oct 27. PMID: 34818216.
Copy Download .nbib Format: NLM
Presentation of Severe Rheumatic Mitral Stenosis at the Peak of the COVID-19 Pandemic and the Presumptive Treatment as Severe Coronavirus Illness.

European journal of case reports in internal medicine

Balfe C, O'Connor C, Giblin G, Walsh K, Casserly I, Moore D, Maher V.
PMID: 33457355
Eur J Case Rep Intern Med. 2020 Nov 04;7(12):001957. doi: 10.12890/2020_001957. eCollection 2020.

This case report describes a young female Caucasian patient with newly presenting severe mitral stenosis at the peak of the coronavirus pandemic in the Republic of Ireland. The initial presumptive diagnosis was of severe coronavirus illness. This case report...

Cite
Balfe C, O'Connor C, Giblin G, et al. Presentation of Severe Rheumatic Mitral Stenosis at the Peak of the COVID-19 Pandemic and the Presumptive Treatment as Severe Coronavirus Illness. Eur J Case Rep Intern Med. 2020;7(12):001957doi: 10.12890/2020_001957.
Balfe, C., O'Connor, C., Giblin, G., Walsh, K., Casserly, I., Moore, D., & Maher, V. (2020). Presentation of Severe Rheumatic Mitral Stenosis at the Peak of the COVID-19 Pandemic and the Presumptive Treatment as Severe Coronavirus Illness. European journal of case reports in internal medicine, 7(12), 001957. https://doi.org/10.12890/2020_001957
Balfe, Christopher, et al. "Presentation of Severe Rheumatic Mitral Stenosis at the Peak of the COVID-19 Pandemic and the Presumptive Treatment as Severe Coronavirus Illness." European journal of case reports in internal medicine vol. 7,12 (2020): 001957. doi: https://doi.org/10.12890/2020_001957
Balfe C, O'Connor C, Giblin G, Walsh K, Casserly I, Moore D, Maher V. Presentation of Severe Rheumatic Mitral Stenosis at the Peak of the COVID-19 Pandemic and the Presumptive Treatment as Severe Coronavirus Illness. Eur J Case Rep Intern Med. 2020 Nov 04;7(12):001957. doi: 10.12890/2020_001957. eCollection 2020. PMID: 33457355; PMCID: PMC7806305.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 237 entries